Vigil Neuroscience, Inc.

NASDAQ:VIGL

2.73 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q2
Revenue 0001.93400000000000000
Cost of Revenue 00.1130.1130.1130.110.4740.3830.2740.2530.2460.23700.15100000
Gross Profit 0-0.113-0.1131.821-0.11-0.474-0.383-0.274-0.253-0.246-0.2370-0.15100000
Gross Profit Ratio 0000.94200000000000000
Reseach & Development Expenses 13.77215.5414.32616.78215.41514.90313.83412.19112.79112.09710.3659.1197.818.6486.7533.17722.260.197
General & Administrative Expenses 6.9046.9387.0897.0756.9067.016.9416.6824.8464.9454.9673.8582.9282.1281.1650.8820.8950
Selling & Marketing Expenses 0-0.113-0.113-0.11300000000000000
SG&A 6.9046.8256.9766.9626.9067.016.9416.6824.8464.9454.9673.8582.9282.1281.1650.8820.8950.184
Other Expenses 0-0.003-0.0020.002-0.003-0.007-0.005-0.009-0.026-0.005-0.004-0.008-0.002-0.592-0.275-0.177-1.1550
Operating Expenses 20.67622.36521.30223.74422.32121.91320.77518.87317.63717.04215.33212.97710.73810.7767.9184.05923.1550.381
Operating Income -20.676-22.478-21.415-23.857-22.321-21.913-20.775-18.873-17.637-17.042-15.332-12.977-10.738-10.776-7.918-4.059-23.155-0.381
Operating Income Ratio 000-12.33600000000000000
Total Other Income Expenses Net 1.4181.2511.4751.6831.8261.7390.980.4170.1370.027-0.002-0.008-0.002-0.591-0.273-0.177-1.1550
Income Before Tax -19.258-21.227-19.94-22.174-20.495-20.174-19.795-18.456-17.5-17.015-15.334-12.985-10.74-11.367-8.191-4.236-24.31-0.381
Income Before Tax Ratio 000-11.46500000000000000
Income Tax Expense 000.072.901-0.11-1.746-1.045-32.791-0.137-0.0270.002-12.980.0020.590.2710.1771.1550
Net Income -19.258-21.227-19.94-22.174-20.495-20.174-18.7514.335-17.363-16.988-15.336-12.985-10.74-11.367-8.191-4.236-24.31-0.381
Net Income Ratio 000-11.46500000000000000
EPS -0.47-0.52-0.5-0.57-0.53-0.52-0.490.37-0.52-0.6-0.58-0.46-0.38-0.54-0.39-0.2-1.15-0.014
EPS Diluted -0.47-0.52-0.5-0.57-0.53-0.52-0.490.37-0.52-0.6-0.58-0.46-0.38-0.54-0.39-0.2-1.15-0.014
EBITDA -20.562-22.365-21.302-23.744-22.211-21.802-20.71-18.852-17.616-17.024-15.314-12.962-10.726-10.77500-23.929-0.381
EBITDA Ratio 000-12.27700000000000000